99 related articles for article (PubMed ID: 32915688)
1. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms.
Clarke LE; Mabey B; Flake Ii DD; Meek S; Cassarino DS; Duncan LM; High WA; Napekoski KM; Prieto VG; Tetzlaff MT; Vitale P; Elder DE
Per Med; 2020 Sep; 17(5):361-371. PubMed ID: 32915688
[No Abstract] [Full Text] [Related]
2. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
3. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
4. Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
Castillo SA; Pham AK; Dagrosa AT; Yan S; Barton DT; Lefferts JA; Linos K
Am J Dermatopathol; 2020 Dec; 42(12):939-947. PubMed ID: 32675469
[TBL] [Abstract][Full Text] [Related]
5. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.
Minca EC; Al-Rohil RN; Wang M; Harms PW; Ko JS; Collie AM; Kovalyshyn I; Prieto VG; Tetzlaff MT; Billings SD; Andea AA
Mod Pathol; 2016 Aug; 29(8):832-43. PubMed ID: 27174586
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
7. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists.
Cockerell CJ; Tschen J; Evans B; Bess E; Kidd J; Kolquist KA; Rock C; Clarke LE
Medicine (Baltimore); 2016 Oct; 95(40):e4887. PubMed ID: 27749545
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.
Clarke LE; Warf MB; Flake DD; Hartman AR; Tahan S; Shea CR; Gerami P; Messina J; Florell SR; Wenstrup RJ; Rushton K; Roundy KM; Rock C; Roa B; Kolquist KA; Gutin A; Billings S; Leachman S
J Cutan Pathol; 2015 Apr; 42(4):244-52. PubMed ID: 25727210
[TBL] [Abstract][Full Text] [Related]
9. A diagnostically-challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23-gene expression signature (myPath melanoma).
Castillo SA; Pham AK; Barton DT; Lefferts JA; Yan S; Bridge JA; Linos K
J Cutan Pathol; 2019 Mar; 46(3):226-230. PubMed ID: 30506910
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
[TBL] [Abstract][Full Text] [Related]
11. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
12. Correlation of melanoma gene expression score with clinical outcomes on a series of melanocytic lesions.
Ko JS; Clarke LE; Minca EC; Brown K; Flake DD; Billings SD
Hum Pathol; 2019 Apr; 86():213-221. PubMed ID: 30566894
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
14. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
[TBL] [Abstract][Full Text] [Related]
15. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Lee JJ; Vilain RE; Granter SR; Hu NR; Bresler SC; Xu S; Frank AH; Mihm MC; Saw RP; Fletcher CD; Scolyer RA; Murphy GF; Lian CG
J Cutan Pathol; 2017 Mar; 44(3):249-255. PubMed ID: 28032662
[TBL] [Abstract][Full Text] [Related]
17. SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.
Willmes C; Kumar R; Becker JC; Fried I; Rachakonda PS; Poppe LM; Hesbacher S; Schadendorf D; Sucker A; Schrama D; Ugurel S
Oncotarget; 2016 Mar; 7(9):10117-32. PubMed ID: 26799424
[TBL] [Abstract][Full Text] [Related]
18. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
Wang LX; Li Y; Chen GZ
PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
[TBL] [Abstract][Full Text] [Related]
19. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
20. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
